Good MorningEquity markets rebounded on Wednesday, but the move may be short-lived. Data due today may reinforce the idea of hot inflation and Fed hawkishness, pushing the timeline for rate cuts out another few months. Among the causes for concern is a spike in mortgage rates, with home buyers pulling back. Another is a risk to the banking sector due to higher for longer interest rates. The risk to small and regional banks is growing by the day, and some may not last until the FOMC decides lower rates are acceptable.
Among the data points due out today is Retail Sales. Retail Sales are expected to fall compared to last year but may outpace consensus due to higher prices at the register and lingering consumer resilience at home. On the one hand, a decline in retail sales may indicate the start of a larger economic slowdown, while on the other hand, a hot read will keep the Fed policy tight. In both cases risk for equities abounds. Featured: Free SMS Stock Alerts from MarketBeat (Ad) 
|
Stocks | | |
The oil refiners' exchange-traded fund (ETF), the VanEck Oil Refiners ETF (NYSEARCA: CRAK), is outperforming the broader Energy Select Sector SPDR Fund (NYSEARCA: XLE) on a one-month, three-month and one-year basis.
The top components in the CRAK ETF are Marathon Petrole... Read the Full Story |
|
From Our Partners | Will you be Larry's next breakout protégé?
For the past three years, Larry Benedict's "protégés" have had the chance to beat the market by 8x.
But it hasn't happened the usual way.
It's all thanks to something he calls the "Market Wizard Protégé Program."
For every dollar others make, you could make 2x, 5x, even 10x more — using the same stocks.
It almost sounds like magic, but it's true.
Is this radical program suitable for you? | | Click here to see for yourself — including the #1 stock Larry recommends trading today. |
|
Markets | | |
There are many ways to collect income from the stocks. Dividends first come to mind as they pay out a small percentage of the stock price and the number of shares you own in cash, usually on a quarterly basis. However, it takes capital to buy and hold the underlying shares. If you already own stoc... Read the Full Story |
|
Stocks | | |
2024 is shaping up to be a pivotal year for the biotechnology industry.
In recent years, emergency Covid vaccines have ushered in several groundbreaking innovations that have changed the way drugs are developed and health care is administered. Advancements in the treatment of cancer, Alzheimer&rs... Read the Full Story |
|
From Our Partners | | President Trump’s “Project MAFA”
Get a look inside Trump’s genius master plan to create a “new” gold standard, smash the U.S. debt, and kick off a Golden Century before July 25. | | You can get all the details here. |
|
Markets | | |
There’s perhaps never been a divergence like it. While the tech-heavy Nasdaq index has tacked on almost 10% since the first week of January, shares of electric vehicle (EV) giant Tesla Inc (NASDAQ: TSLA) have sunk more than 20%. And the worst part for Tesla investors is that it has... Read the Full Story |
|
Markets | | | Shares of JetBlue are up more than 18% in Tuesday afternoon trading as activist investor Carl Icahn took an almost 10% stake in the airline. Icahn, who purchased the shares in January and February, said in a regulatory filing that he believe JetBlue's stock is undervalued and represents an attractiv... Read the Full Story |
|
From Our Partners | | New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun.
Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation. | | See Altucher’s Trump crypto prediction here |
|
Markets | | | Japan’s economy is now the world’s fourth-largest after it contracted in the last quarter of 2023 and fell behind Germany. The government reported the economy shrank at an annual rate of 0.4% in October to December, according to Cabinet Office data on real GDP released Thursday, though it grew 1.9% ... Read the Full Story |
|
Markets | | |
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. The shot heard around the world in the medical sector occurred on December 8, 2023, when the U.S. FDA approved Casgevy, the first FDA... Read the Full Story |
|
Markets | | | The British economy fell into recession at the end of 2023 for the first time since the onset of the coronavirus pandemic, as output shrank more than anticipated in the final three months of the year, official figures showed Thursday.In what is a blow for the governing Conservative Party ahead of a ... Read the Full Story |
|
Markets | | | Lyft shares jumped 62% after the bell Tuesday thanks in part to a typo in the ride-hailing company’s earnings release that sent investors’ auto-trading algorithms — also known as “bots” — into a buying frenzy Read the Full Story |
|
Markets | | | Jayson Tatum remembers how it felt when he first bought a home. “It didn’t seem real,” said the Boston Celtics power forward, a five-time NBA All-Star set to start for the Eastern Conference in this year's All-Star Game on Sunday. Tatum told The Associated Press in an interview how he wants to help ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. | | View Today's Stock Pick |
|
